The scales for distribution of leukemia patients according to the therapy response, drug sensitivity or resistance of tumor cells, MDR1 mRNA and P-gp expression levels, and the presence or absence of prognostic immunological and genetic markers were developed for subsequent correlation analysis. Here, PGP is linked to neoplasm.